Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies

被引:22
|
作者
Evenden, D.
Harper, P. R. [1 ]
Brailsford, S. C.
Harindra, V.
机构
[1] Univ Southampton, Sch Med, Southampton SO17 1BJ, Hants, England
[2] Univ Southampton, Sch Management, Southampton SO17 1BJ, Hants, England
[3] St Marys Hosp, Portsmouth PO3 6AQ, Hants, England
关键词
healthcare; Chlamydia; system dynamics; geomapping; risk grouping;
D O I
10.1057/palgrave.jors.2602134
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Chlamydia is the most common sexually transmitted infection in the UK and constitutes a major public health problem. The UK Department of Health is phasing in a National Chlamydia Screening Programme (NCSP) but there is concern that blanket screening of the entire at risk population will simply add extra burden to the already overstretched health economy. This paper demonstrates that certain high- risk sub-groups within the general population are critical in the infection dynamics. Improved targeting of these high- risk populations achieves greater cost-effectiveness. Statistical risk- group clustering techniques have been used to identify indicators that are strong predictors in determining high- risk status while geomapping techniques visually display prevalence geographically across the region, thus identifying high prevalence postcode clusters and informing public health planners where to target intervention and screening strategies. A System Dynamics simulation model has been used to capture the infection dynamics and measure the cost-effectiveness of the intervention strategies. The model incorporates risk- group behaviour as identified by the above geomapping and statistical analysis components of the research. The combined use of computer simulation, statistical analysis and geomapping methodologies has provided a unique holistic view of the problem.
引用
收藏
页码:1400 / 1412
页数:13
相关论文
共 50 条
  • [21] Cost-effectiveness of screening and management strategies for chlamydia control in Hong Kong: abridged secondary publication
    Wong, W. C. W.
    Wong, C.
    Ong, J.
    Fairley, C.
    Hocking, J.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (01) : 27 - 31
  • [22] Re: Improving the cost-effectiveness of colorectal cancer screening
    Loeve, F
    Brown, ML
    Boer, R
    Habbema, JDF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) : 1691 - 1692
  • [23] Screening strategies for active tuberculosis: focus on cost-effectiveness
    Dobler, Claudia Caroline
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 335 - 347
  • [24] The cost-effectiveness of osteoporosis screening strategies for postmenopausal women
    Nayak, S.
    Greenspan, S. L.
    Liu, H.
    Michaud, K.
    Owens, D. K.
    Roberts, M. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 410 - 411
  • [25] The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland
    Pelczarska, Aleksandra
    Jakubczyk, Michal
    Jakubiak-Lasocka, Joanna
    Banach, Maciej
    Mysliwiec, Malgorzata
    Gruchala, Marcin
    Niewada, Maciej
    ATHEROSCLEROSIS, 2018, 270 : 132 - 138
  • [26] Cost-effectiveness of prenatal HIV screening strategies in Uganda
    Kim, Lena
    Vogel, Sinae
    Cohan, Deborah
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S236 - S236
  • [27] COST-EFFECTIVENESS ANALYSIS OF SARCOPENIA SCREENING STRATEGIES IN IRAN
    Heshmat, R.
    Hemami, M. Rezaei
    Darvishi, A.
    Shafiee, G.
    Daroudi, R.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S392 - S392
  • [28] A cost-effectiveness analysis of newborn hearing screening strategies
    Kemper, AR
    Downs, SM
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (05): : 484 - 488
  • [29] Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women
    Rours, G. I. J. G.
    Smith-Norowitz, Tamar Anne
    Ditkowsky, Jared
    Hammerschlag, Margaret R.
    Verkooyen, R. P.
    de Groot, R.
    Verbrugh, H. A.
    Postma, M. J.
    PATHOGENS AND GLOBAL HEALTH, 2016, 110 (7-8) : 292 - 302
  • [30] Dynamic modelling for estimating the cost-effectiveness of a Chlamydia trachomatis screening program
    De Vries, R
    Postma, MJ
    De Jong-van den Berg, LT
    Van Bergn, J
    VALUE IN HEALTH, 2005, 8 (06) : A57 - A57